Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ISRG vs MRNA✓SelectedUSD · MRNAISRG vs MRNA performance historyLatest closeAs of-1.32%11/16
Stock and ETF performance explorer

ISRG vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+167.1%
MRNA return
+878.5%
Excess return
-711.4%
Maximum drawdown
-49.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.3%-3.6%+2.3%-1.1%
7D-5.0%-20.0%+15.0%-3.8%
30D+2.6%-1.3%+3.8%+2.5%
3M+11.0%+240.0%-229.0%-1.1%
6M+3.9%+339.0%-335.0%-9.8%
YTD-22.7%+630.0%-652.7%-36.3%
1Y-20.3%+769.1%-789.4%-35.4%
3Y+44.0%+181.2%-137.2%+23.9%
5Y+21.2%-8.1%+29.3%+10.9%
All+167.1%+878.5%-711.4%+108.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling